{
    "cancelStatus": "1",
    "cancelDate": "2020-04-13",
    "cancelReason": [
        "851"
    ],
    "licid": "60000946",
    "validDate": "2018-09-04 00:00:00.000",
    "issueDate": "2013-09-04 00:00:00.000",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000094600",
    "prodNameC": "克癌平 凍晶注射劑440毫克",
    "prodNameE": "Herclon 440mg",
    "indicationsName": [
        "Herclon應使用於下列HER2過度表現或HER2基因amplification之早期乳癌、轉移性乳癌患者\r\n\r\n說明：\r\n1.早期乳癌(EBC)：\r\n(1)經外科手術、化學療法(術前或術後)之輔助療法。\r\n(2)以doxorubicin與cyclophosphamide治療，再合併pactlitaxel或docetaxel之輔助療法。\r\n(3)與docetaxel及carboplatin併用之輔助療法。\r\n(4)術前與化學療法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)\r\n\r\n2.轉移性乳癌(MBC)：\r\n(1)單獨使用於曾接受過一次(含)以上化學療法之轉移性乳癌；除非患者不適合使用anthracyclin或taxane，否則先前之化學治療應至少包括anthracyclin或taxane。\r\n使用於荷爾蒙療法失敗之荷爾蒙受體陽性之患者，除非患者不適用荷爾蒙療法。\r\n(2)與pactlitaxel或docetaxel併用於未曾接受過化學療法之轉移性乳癌。\r\n(3)與芳香環酶抑制劑併用於荷爾蒙受體陽性之轉移性乳癌。\r\n\r\n3.轉移性胃癌(MGC)：\r\nHerclon合併capecitabine(或5-f1uorouracil)及cisplatin適用於未曾接受過化學治療之HER2過度表現轉移性胃腺癌(或胃食道接合處腺癌)的治療。"
    ],
    "does": "2243",
    "packageUnit": [
        {
            "packageSpec": "每小瓶附溶劑20毫升，100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": null,
    "ingredientsDesc": [
        "TRASTUZUMAB"
    ],
    "restraintItemsCode": null,
    "applicantName": "台灣羅氏醫療診斷設備股份有限公司",
    "applicantAddr": "台北市中山區民權東路3段2號10樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "GENENTECH INC.",
            "factoryAddr": "4625 NW BROOKWOOD PARKWAY, HILLSBORO OREGON, 97124 USA",
            "factoryCompanyAddr": "",
            "countryCode": "US",
            "processCode": [
                {
                    "value": "1L",
                    "name": "製劑廠"
                }
            ],
            "processCodeStr": "1L;製劑廠",
            "factoryKind": "M",
            "factoryNo": "FUS0767100",
            "factoryInfo": null,
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "F.HOFFMANN-LA ROCHE LTD.",
            "factoryAddr": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "factoryCompanyAddr": null,
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "6D",
                    "name": "次包裝廠"
                }
            ],
            "processCodeStr": "6D;次包裝廠",
            "factoryKind": "M",
            "factoryNo": "FCH0208000",
            "factoryInfo": null,
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "GENENTECH, INC.",
            "factoryAddr": "1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USA",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FUS0767000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000500",
            "ingredientsDesc": "TRASTUZUMAB",
            "concentDesc": "",
            "concent": "440.000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01XC03"
        }
    ],
    "licBaseId": "84F8B0C1-F750-4F57-AC10-AFD57F7A0BD3"
}